Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Multiple Sclerosis (MS) using standard diagnostic guidelines called the McDonald 2017 criteria
- You are between 18 and 65 years old
- Your MS has been stable for the past 12 months, meaning no relapses, no new activity on brain/spine scans, and no worsening of disability
- You have been on the same MS medication without any changes for the past 12 months
- You are fully able to walk without significant difficulty (confirmed by a standard MS disability scale score below 4)
- You are able to read, understand, and sign a consent form yourself
Who may not be able to join:
- You have severe depression (based on a standard depression questionnaire score) or another diagnosed psychiatric condition
- You have a serious problem with your immune system, other than a specific condition involving low antibody levels in the blood
- You are currently receiving, or have been told you need, immunoglobulin (antibody) replacement treatment
- You experience very severe daytime sleepiness, based on a standard sleepiness questionnaire score
- You have certain conditions or take certain medications that could worsen fatigue, such as liver, kidney, or thyroid problems, substance misuse, use of tranquilisers, anti-epileptic drugs, or psychiatric medications, or a long-term infectious disease such as hepatitis or HIV
- You have another neurological degenerative condition or another autoimmune disease alongside your MS
- You are not able to give written consent yourself
- You are under 18, pregnant, or currently in prison
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lara Diem, MD, Inselspital University Hospital of Bern
Phone: 0041316327000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with fatigue and hypogammaglobulinemia; Number of patients with fatigue without hypogammaglobulinemia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.